Xenograft and Syngeneic Tumor Models in Rats - WuXi Biology

Xenograft and Syngeneic Tumor Models in Rats

Leverage our extensive panel of rat xenograft and syngeneic tumor models.

Advantages for using rats in preclinical efficacy studies compared with mice include:

  • more similar metabolism and physiology to human;
  • easier use for orthotopic model surgery, vascular manipulation, and imaging;
  • larger sampling sizes to ensure sufficient amount for bioanalysis;
  • consistent animal species to toxicology studies

 



Xenograft and syngeneic tumor models in rats-OncoWuXi Newsletter

Download

← Return to Resources

Related Content

In this webinar, WuXi AppTec scientists discuss the latest innovative technologies and products in early-stage drug discovery. Viewers will gain...

VIEW RESOURCE

Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...

VIEW RESOURCE
← View all Candidate Selection Resources
× peptide, amino acid

Contact An Expert Today!